GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 2cureX AB (OSTO:2CUREX) » Definitions » Net Margin %

2cureX AB (OSTO:2CUREX) Net Margin % : -11,682.76% (As of Sep. 2023)


View and export this data going back to 2017. Start your Free Trial

What is 2cureX AB Net Margin %?

Net margin is calculated as Net Income divided by its Revenue. 2cureX AB's Net Income for the three months ended in Sep. 2023 was kr-10.16 Mil. 2cureX AB's Revenue for the three months ended in Sep. 2023 was kr0.09 Mil. Therefore, 2cureX AB's net margin for the quarter that ended in Sep. 2023 was -11,682.76%.

The historical rank and industry rank for 2cureX AB's Net Margin % or its related term are showing as below:

OSTO:2CUREX' s Net Margin % Range Over the Past 10 Years
Min: -33077.78   Med: -19875.06   Max: -6672.34
Current: -13257.03


OSTO:2CUREX's Net Margin % is ranked worse than
92.43% of 1031 companies
in the Biotechnology industry
Industry Median: -155.67 vs OSTO:2CUREX: -13257.03

2cureX AB Net Margin % Historical Data

The historical data trend for 2cureX AB's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

2cureX AB Net Margin % Chart

2cureX AB Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Net Margin %
Get a 7-Day Free Trial - - - - -33,077.78

2cureX AB Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -80,037.50 -8,679.27 -58,269.23 -12,170.15 -11,682.76

Competitive Comparison of 2cureX AB's Net Margin %

For the Biotechnology subindustry, 2cureX AB's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


2cureX AB's Net Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 2cureX AB's Net Margin % distribution charts can be found below:

* The bar in red indicates where 2cureX AB's Net Margin % falls into.



2cureX AB Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

2cureX AB's Net Margin for the fiscal year that ended in Dec. 2022 is calculated as

Net Margin=Net Income (A: Dec. 2022 )/Revenue (A: Dec. 2022 )
=-29.77/0.09
=-33,077.78 %

2cureX AB's Net Margin for the quarter that ended in Sep. 2023 is calculated as

Net Margin=Net Income (Q: Sep. 2023 )/Revenue (Q: Sep. 2023 )
=-10.164/0.087
=-11,682.76 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


2cureX AB  (OSTO:2CUREX) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


2cureX AB Net Margin % Related Terms

Thank you for viewing the detailed overview of 2cureX AB's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


2cureX AB (OSTO:2CUREX) Business Description

Traded in Other Exchanges
Address
Fruebjergvej 3, Copenhagen, DNK, DK-2100
2cureX AB is a biotech company. The company is engaged in improving treatment efficiency, mainly for cancer patients. It is involved in developing a product, namely IndiTreat, which is a technology for the treatment of colorectal, ovarian, and pancreatic cancers. The company's sub-products include IndiTreat Test, IndiTreat clinical programs, and IndiTreat Therapy Design.

2cureX AB (OSTO:2CUREX) Headlines

No Headlines